Internal Hernia after Laparoscopic Roux-en-Y Gastric Bypass for Morbid Obesity: A Continuous Challenge in Bariatric Surgery

2006 ◽  
Vol 16 (11) ◽  
pp. 1482-1487 ◽  
Author(s):  
A Paroz ◽  
J Calmes ◽  
V Giusti ◽  
M Suter
2010 ◽  
Vol 29 (2) ◽  
pp. E15 ◽  
Author(s):  
Jared M. Pisapia ◽  
Casey H. Halpern ◽  
Noel N. Williams ◽  
Thomas A. Wadden ◽  
Gordon H. Baltuch ◽  
...  

Object Roux-en-Y gastric bypass is the gold standard treatment for morbid obesity, although failure rates may be high, particularly in patients with a BMI > 50 kg/m2. With improved understanding of the neuropsychiatric basis of obesity, deep brain stimulation (DBS) offers a less invasive and reversible alternative to available surgical treatments. In this decision analysis, the authors determined the success rate at which DBS would be equivalent to the two most common bariatric surgeries. Methods Medline searches were performed for studies of laparoscopic adjustable gastric banding (LAGB), laparoscopic Roux-en-Y gastric bypass (LRYGB), and DBS for movement disorders. Bariatric surgery was considered successful if postoperative excess weight loss exceeded 45% at 1-year follow-up. Using complication and success rates from the literature, the authors constructed a decision analysis model for treatment by LAGB, LRYGB, DBS, or no surgical treatment. A sensitivity analysis in which major parameters were systematically varied within their 95% CIs was used. Results Fifteen studies involving 3489 and 3306 cases of LAGB and LRYGB, respectively, and 45 studies involving 2937 cases treated with DBS were included. The operative successes were 0.30 (95% CI 0.247–0.358) for LAGB and 0.968 (95% CI 0.967–0.969) for LRYGB. Sensitivity analysis revealed utility of surgical complications in LRYGB, probability of surgical complications in DBS, and success rate of DBS as having the greatest influence on outcomes. At no values did LAGB result in superior outcomes compared with other treatments. Conclusions Deep brain stimulation must achieve a success rate of 83% to be equivalent to bariatric surgery. This high-threshold success rate is probably due to the reported success rate of LRYGB, despite its higher complication rate (33.4%) compared with DBS (19.4%). The results support further research into the role of DBS for the treatment of obesity.


2019 ◽  
Vol 34 (6) ◽  
pp. 2519-2531 ◽  
Author(s):  
Cristina Vicente Martin ◽  
Luis R. Rabago Torre ◽  
Luis A. Castillo Herrera ◽  
Marisa Arias Rivero ◽  
Miguel Perez Ferrer ◽  
...  

Author(s):  
Antônio Nelson Alencar de Araújo ◽  
Marcos Alexandre Casimiro de Oliveira

Introduction: Morbid obesity is characterized by a state of insulin-resistance and is often associated with metabolic syndrome, increasing overall and cardiovascular mortality. Due to the unsatisfactory results in conventional treatment in specific groups of patients, invasive intervention is an alternative. However, it may be indicated, especially in situations where the patient has severe obesity or morbid obesity. Objective: The present study aims to evaluate the changes in metabolic syndrome parameters after bariatric surgery. Methodology: This is an integrative review of the literature performed through searches in the Scielo, LILACS and PUBMED databases using the following Controlled Health Sciences Descriptors (DeCS): Bariatric Surgery, Gastric Bypass, Obesity and Metabolic Syndrome. The inclusion criteria were: articles in English or Portuguese, text in full, publications in the period from 2009 to 2019 in article format that addressed the theme described. Duplicate publications, articles that did not address the theme after reading the respective abstracts and articles that do not meet the objectives of this study were excluded. Results: According to the analysis of the results, a reduction of 86.1% in the prevalence of metabolic syndrome was observed; 65.3% in arterial hypertension and 84.2% in altered fasting glycemia. A normalization of abdominal circumference in 35.4% of patients, an increase in 35.8% in HDL levels and high triglyceride values may be observed. Among the results obtained, the increase in HDL did not obtain great relevance, as well as the decrease in abdominal circumference. Conclusion: The study showed a positive relationship between bariatric surgery and metabolic syndrome parameters. The results presented were favorable when surgery was associated with a healthy lifestyle and factors that contribute to the effective coping of this condition in most of the cases analyzed. However, multiprofessional follow-up, particularly for medical, nutritional and psychological care, is essential to have a positive impact on the quality of life of these patients.


2009 ◽  
Vol 23 (3) ◽  
pp. 215-216 ◽  
Author(s):  
Maya Doumit ◽  
Gaby Doumit ◽  
Farid M Shamji ◽  
Sylvie Gregoire ◽  
Richard E Seppala

The Roux-en-Y gastric bypass is one of the most common operations for morbid obesity. Although rare, gastropulmonary fistulas are an important complication of this procedure. There is only one recently reported case of this complication. The present report describes the serious nature of this complication in a patient after an uneventful laparoscopic gastric bypass surgery.


2006 ◽  
Vol 16 (10) ◽  
pp. 1265-1271 ◽  
Author(s):  
Antonio Iannelli ◽  
Enrico Facchiano ◽  
Jean Gugenheim

2021 ◽  
Author(s):  
V. O. Nevmerzhytskyi

Over the last few decades, excess weight and obesity have become a considerable health problem that has a lasting impact on communities worldwide. According to the WHO, about 1.9 billion people over the age of 18 are overweight [32]. Obesity accounted for about 4.7 million premature deaths in 2017. Globally, obesity was associated with an increase in mortality rate from 4.5 % in 1990 to 8 % in 2017 [32]. Bariatric surgery is currently recognized as the most effective treatment option for morbid obesity. Over the past 10 years, gastric bypass surgery has proved more effective than any other surgical methods due to its optimal metabolic effects. The aim of the review is to carry out an analysis of literature data in order to identify main complications after gastric bypass in patients with obesity. The complication rate after bariatric surgery decreased from 10.5 % in 1993 to 7.6 % in 2006 [3]. The mortality rate after bariatric surgery was 0.08 % within 30 days after surgery and 0.31 % after 30 days [13]. According to the BOLD study (2010), for 57,918 bariatric operations, the complication rate was 6,240 (10.77 %) and the mortality rate was 78 (0.135 %), within 30 days after surgery — 0.089 %, within 90 days after surgery — 0.112 %. Roux‑en‑Y Gastric Bypass (RYGB) was carried out in 30,864 cases, and 4,588 (14.87 %) patients developed postoperative complications. Early complications include anastomotic leaks (0 — 5,6 % for laparoscopic approach and 1,6 — 2,6 % — for laparotomy), small bowel obstruction caused by a blood clot (0 — 0,5 %), bleeding from the sutures (1,5 %), and thromboembolic complications (0,2 — 5 %). Late complications include stenosis of the gastrointestinal tract (3 — 27 %), marginal ulceration (MU) — 0,6 — 16 %, an incarcerated Petersen’s space hernia — 2,51 %, perforation of the stomach and small intestine (1 — 2 %), gastrogastric fistula formation — 1,5 — 6,0 %, weight regain (to 17,1 %). Increasing global demand for bariatric surgery as the best option for the management of excess weight and obesity necessitates more detailed investigation of possible complications it may induce. Therefore, further research is required to develop and study new effective methods for prevention and treatment of complications after surgical treatment of patients with morbid obesity.  


2020 ◽  
Vol 30 (12) ◽  
pp. 5177-5178
Author(s):  
Theodoros Thomopoulos ◽  
Styliani Mantziari ◽  
Penelope St-Amour ◽  
Emilie Uldry ◽  
Michel Suter

Abstract Background Small bowel obstruction (SBO) due to internal hernia (IH) is a well-known late complication after laparoscopic Roux-en-Y gastric bypass (LRYGB), with an incidence between 0.5 and 10% as reported by Iannelli et al. (Obes Surg. 17(10):1283–6, 2007). It is reported most frequently 1–2 years after surgery because of the greater weight loss at that time, with rapid loss of the mesenteric fat consequently as discussed by Stenberg et al. (Lancet. 387(10026):1397–404, 2016). Currently, women constitute more than 50% of the patients undergoing bariatric surgery and most of them are of childbearing age as reported by the World Health Organization (2015). SBO, due to IH, is a rare complication during pregnancy, mostly occurring during the third trimester as discussed by Torres-Villalobos et al. (Obes Surg 19(7):944–50, 2009), and can result in fetal and maternal morbidity and even mortality as reported by Vannevel et al. (Obstet Gynecol. 127(6):1013–20, 2016). Moreover, the physiologic changes of pregnancy can mask the symptoms of SBO after LRYGB, leading to significant diagnostic and therapeutic delays as detailed by Wax et al. (Am J Obstet Gynecol 208(4):265–71, 2013). Therefore, an early surgical exploration is necessary in this particular and uncommon situation as discussed by Webster et al. (Ann R Coll Surg Engl 97(5):339–44, 2015). Methods A 32-year-old female patient, with Ehlers-Danlos syndrome and chronic pain, was in the 28th week of her first pregnancy after bariatric surgery. She had had an antecolic LRYGB 6 years ago in another institution, resulting in a 35-kg weight loss. She presented to the emergency department with severe and persistent epigastric pain associated with nausea and vomiting during 24 h. On physical examination, her abdomen was painful and tender at the epigastrium and left hypochondrium, and her vital signs were normal. The blood tests were in the normal range except the white blood cell count at 12′000 G/l. The obstetric and neonatal team was involved, and fetal heart monitoring was normal. Abdominal ultrasonography ruled out other causes of pain. An abdominal MRI was performed and displayed a distended proximal small bowel, free abdominal fluid, and bowel mesenteric edema in the left upper quadrant with compression of the superior mesenteric vein. Internal hernia with intestinal suffering was suspected, and the patient consented for emergency laparoscopy. Results The laparoscopic exploration, reduction of the internal hernia, and closure of the mesenteric defects are demonstrated step-by-step in the presented intraoperative video. The postoperative course was uncomplicated for both patient and fetus. Oral feeding was resumed at day 1, with no residual symptom, and the patient was discharged on postoperative day 3. At 1-month follow-up, she had no complaint and her pregnancy had resumed a normal course. She delivered a healthy baby at 36 weeks without any complication. Conclusions Internal herniation after LRYGB represents a rare, high-risk complication during pregnancy. A low threshold for imaging, preferably by abdominal MRI, is recommended. Multidisciplinary management, including obstetricians and bariatric surgeons, is necessary in order to avoid maternal and fetal adverse outcomes. During surgery, recognition of the anatomy is often difficult, and parts of the bowel are distended and fragile. Starting to run the bowel backwards from the ileocecal valve is a crucial surgical step for reducing internal hernias during LRYGB, and reduces both the risk to worsen the situation and of bowel injury, making its management less hazardous.


Sign in / Sign up

Export Citation Format

Share Document